Featured Content

Articles

New Pill Offers Hope Against Pancreatic Cancer 

A new pill can reportedly double survival in early pancreatic cancer trials, raising cautious optimism about a disease that has long resisted treatment. Revolution Medicines’ daraxonrasib targets KRAS, a gene that supplies instructions for the development of the K-Ras protein which is essentially a switch for controlling cell division, growth, and death.  Daraxonrasib belongs to a class of targeted therapies dubbed RAS … Continue reading “New Pill Offers Hope Against Pancreatic Cancer “

TinyGemsBreaks

TinyGemsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) Highlights Pipeline Expansion and Clinical Milestones in Mid-Year Shareholder Update

Kairos Pharma (NYSE American: KAPA) provided a mid-year 2026 update highlighting plans to expand its oncology pipeline through the proposed acquisition of worldwide rights to CL-741, a Phase 1-ready oral c-MET kinase inhibitor from Celyn Therapeutics targeting EGFR-mutated lung cancer and other cancers. The company said CL-741 would complement its existing portfolio, which includes ENV-105, … Continue reading “TinyGemsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) Highlights Pipeline Expansion and Clinical Milestones in Mid-Year Shareholder Update”

Sector News

Filter Releases
Sectors



Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}

NewsRoom

Receive Alerts from TinyGems

Text "Gems" to 888-902-4192

(US Mobile Phones Only)

About TinyGems

Discover diamonds in the rough with TinyGems.

TinyGems spotlights emergent small-cap companies with bright futures and big potential. Small and yet unproven, there’s obvious risk but also huge upside possibilities for investors in the know. Contrary to conventional dogma, shares of small-cap and mid-cap companies posted far superior total returns than mega-cap stocks since December 1999.

Don’t overlook the innovation of disruptive small-cap companies on the cusp of market discovery. TinyGems puts a spotlight on the best and brightest of these disruptors that have the technology, the talent, the drive, and the business models to make a huge impact in the markets and in portfolios.

More About TinyGems    Schedule a Live Online Demo

Contact us: (512) 354-7000